VAC4EU Logo
VAC4EU Logo
  • About
    About VAC4EU
    • Is a not-for profit international association, with institutional memberships (study network)
    • Provides access to a well characterised public study network, which can provide data access and perform studies for different internal and external requesters such as vaccine manufacturers, European Commission, regulators, public health institutes.
    Learn more Become a member
    Organization
    • Vision, mission and history
      • Code of conduct
    • How we work
      • Governance
      • Members
      • Working groups
    • Collaborations
  • Study pipeline
    • Data sources
    • The VAC4EU Toolbox
  • Projects and Studies
  • Results
  • News
  • Resources
    • Content hub
    • Journal club
    • Template protocols
    • Background rates dashboard
    • VaccO
    • Vaccine effectiveness
    • IR interrelations
  • Contact us
Search VAC4EU

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience

Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women

Impact and Effectiveness of COVID-19 mRNA VaccinationAgainst COVID-19 Hospitalisation in Paediatrics: A CohortStudy Using Two Linked Data Sources in Spain

Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials “

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway

Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study

Next →

Join our community

Subscribe to our newsletter to receive the latest updates, news, and events from the VAC4EU project.

VAC4EU Logo

VAC4EU (Vaccine monitoring Collaboration for Europe) is the sustainability solution of the ADVANCE project which was funded by the Innovative Medicines Initiative from October 2013 - March 2019.

Contact

secretariat@vac4eu.org

Navigation
  • Home
  • About
  • Projects and Studies
  • Results
  • Resources
  • Contact
About
  • Vision, mission and history
  • How we work
  • Collaborations
  • Study pipeline
Resources
  • Template protocols
  • Journal club
  • Background rates
  • Content hub
Outputs
  • Publications
  • Deliverables
  • Presentations

© VAC4EU. All rights reserved.

Privacy Policy